论文部分内容阅读
Objective Triple-negative breast cancer(TNBC),which accounts for 15%to 20%of all breast cancer cases,is an aggressive subtype characterized by absence or minimal expression of estrogen receptor(ER)and progesterone receptor(PR)and lack of the human epidermal growth factor receptor 2(HER2)amplification.